These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 1971431)

  • 1. Dynorphin prolongs the action potential of mouse sensory ganglion neurons by decreasing a potassium conductance whereas another specific kappa opioid does so by increasing a calcium conductance.
    Shen KF; Crain SM
    Neuropharmacology; 1990 Apr; 29(4):343-9. PubMed ID: 1971431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynorphin prolongs the action potential duration of mouse sensory ganglion neurons by decreasing a K+ conductance whereas the specific kappa opioid, U-50,488H does so by increasing a Ca2+ conductance.
    Shen KF; Crain SM
    Prog Clin Biol Res; 1990; 328():343-6. PubMed ID: 1968268
    [No Abstract]   [Full Text] [Related]  

  • 3. Dual opioid modulation of the action potential duration of mouse dorsal root ganglion neurons in culture.
    Shen KF; Crain SM
    Brain Res; 1989 Jul; 491(2):227-42. PubMed ID: 2548663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opioids excite rather than inhibit sensory neurons after chronic opioid exposure of spinal cord-ganglion cultures.
    Crain SM; Shen KF; Chalazonitis A
    Brain Res; 1988 Jul; 455(1):99-109. PubMed ID: 2458169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kappa agonists inhibit gastric emptying but not acid secretion in rhesus monkeys.
    Touzeau PL; Shea-Donohue T
    J Pharmacol Exp Ther; 1990 Jun; 253(3):1010-6. PubMed ID: 1972746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. After GM1 ganglioside treatment of sensory neurons naloxone paradoxically prolongs the action potential but still antagonizes opioid inhibition.
    Crain SM; Shen KF
    J Pharmacol Exp Ther; 1992 Jan; 260(1):182-6. PubMed ID: 1731037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Actions of mu, delta and kappa opioid agonists and antagonists on mouse primary afferent neurons in culture.
    Werz MA; Grega DS; MacDonald RL
    J Pharmacol Exp Ther; 1987 Oct; 243(1):258-63. PubMed ID: 2822900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Voltage-dependent effects of opioid peptides on hippocampal CA3 pyramidal neurons in vitro.
    Moore SD; Madamba SG; Schweitzer P; Siggins GR
    J Neurosci; 1994 Feb; 14(2):809-20. PubMed ID: 7905518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spinal involvement of both dynorphin A and Met-enkephalin in the antinociception induced by intracerebroventricularly administered bremazocine but not morphine in the mouse.
    Tseng LF; Collins KA
    J Pharmacol Exp Ther; 1993 Sep; 266(3):1430-8. PubMed ID: 8103794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual excitatory and inhibitory effects of opioids on intracellular calcium in neuroblastoma x glioma hybrid NG108-15 cells.
    Jin W; Lee NM; Loh HH; Thayer SA
    Mol Pharmacol; 1992 Dec; 42(6):1083-9. PubMed ID: 1336113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Roles of mu, delta and kappa opioid receptors in spinal and supraspinal mediation of gastrointestinal transit effects and hot-plate analgesia in the mouse.
    Porreca F; Mosberg HI; Hurst R; Hruby VJ; Burks TF
    J Pharmacol Exp Ther; 1984 Aug; 230(2):341-8. PubMed ID: 6086883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. kappa- and mu-Opioid inhibition of N-type calcium currents is attenuated by 4beta-phorbol 12-myristate 13-acetate and protein kinase C in rat dorsal root ganglion neurons.
    King AP; Hall KE; Macdonald RL
    J Pharmacol Exp Ther; 1999 Apr; 289(1):312-20. PubMed ID: 10087019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynorphin and neoendorphin peptides decrease dorsal root ganglion neuron calcium-dependent action potential duration.
    Werz MA; Macdonald RL
    J Pharmacol Exp Ther; 1985 Jul; 234(1):49-56. PubMed ID: 2409273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynorphin A decreases voltage-dependent calcium conductance of mouse dorsal root ganglion neurones.
    Macdonald RL; Werz MA
    J Physiol; 1986 Aug; 377():237-49. PubMed ID: 2432242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynorphin reduces voltage-dependent calcium conductance of mouse dorsal root ganglion neurons.
    Werz MA; Macdonald RL
    Neuropeptides; 1984 Dec; 5(1-3):253-6. PubMed ID: 6152324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of the cloned human kappa opioid receptor by agonists enhances [35S]GTPgammaS binding to membranes: determination of potencies and efficacies of ligands.
    Zhu J; Luo LY; Li JG; Chen C; Liu-Chen LY
    J Pharmacol Exp Ther; 1997 Aug; 282(2):676-84. PubMed ID: 9262330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serotonergic involvement in the antinociceptive action of and the development of tolerance to the kappa-opioid receptor agonist, U-50, 488H.
    Ho BY; Takemori AE
    J Pharmacol Exp Ther; 1989 Aug; 250(2):508-14. PubMed ID: 2547935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynorphin selectively augments the M-current in hippocampal CA1 neurons by an opiate receptor mechanism.
    Madamba SG; Schweitzer P; Siggins GR
    J Neurophysiol; 1999 Oct; 82(4):1768-75. PubMed ID: 10515966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of kappa opioid receptors by U50488H and morphine enhances the release of substance P from rat trigeminal nucleus slices.
    Suarez-Roca H; Maixner W
    J Pharmacol Exp Ther; 1993 Feb; 264(2):648-53. PubMed ID: 7679733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maturation of opioid sensitivity of fetal mouse dorsal root ganglion neuron perikarya in organotypic cultures: regulation by spinal cord.
    Chalazonitis A; Crain SM
    Neuroscience; 1986 Apr; 17(4):1181-98. PubMed ID: 3520378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.